Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus - Curigliano, G.; Banerjee, S.; Cervantes, A.; Garassino, M.C.; Garrido, P.; Girard, N.; Haanen, J.; Jordan, K.; Lordick, F.; Machiels, J.P.; Michielin, O.; Peters, S.; et al. (Annals of oncology, 2020)
Keywords: Betacoronavirus; Consensus; Coronavirus Infections - epidemiology; Coronavirus Infections - immunology; Coronavirus Infections - therapy; COVID-19; Disease Management; Europe - epidemiology; Granulocyte Colony-Stimulating Factor - pharmacology; Granulocyte Colony-Stimulating Factor - therapeutic use; Humans; Medical Oncology - methods; Medical Oncology - standards; Neoplasms - epidemiology; Neoplasms - immunology; Neoplasms - therapy; Pandemics - prevention & control; Pneumonia, Viral - epidemiology; Pneumonia, Viral - immunology; Pneumonia, Viral - therapy; Real-Time Polymerase Chain Reaction - methods; Real-Time Polymerase Chain Reaction - standards; SARS-CoV-2; Societies, Medical - standards; Special; T-Lymphocytes, Cytotoxic - drug effects; T-Lymphocytes, Cytotoxic - immunology; Telemedicine - methods; Telemedicine - standards; Europe